Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2026-02-28 @ 9:31 AM
Study NCT ID:
NCT00624702
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2008-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-15
First Submit QC Date:
None
Study First Post Date:
2008-02-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-16
Last Update Post Date:
2020-12-19
Last Update Post Date Type:
ACTUAL